Deloitte life sciences & health care team celebrates corporate finance award success
The corporate finance life sciences & health care team at Deloitte, the business advisory firm, is celebrating after being named Corporate Financier of the Year at this year’s HealthInvestor Awards ceremony.
The corporate finance life sciences & health care team was praised by the judges for the diversity and breadth of work undertaken in the challenging markets of the last year. The judges also commended the team’s significant number of innovative achievements across the independent healthcare sector, life sciences industries and NHS M&A.
David Jones, head of the corporate finance life sciences & health care team at Deloitte, commented: “This award is testament to the breadth, depth and quality of the life sciences and health care practice at Deloitte. It recognises the extent to which the health care team has expanded its services offering and the commitment of our people to generate fresh thinking and produce progressive market solutions for our clients.”
Now in its fourth year, the HealthInvestor Awards is one the most prestigious events in the industry’s calendar promoting excellence and recognising innovation in the healthcare sector.
Notes to Editors:
In this press release references to Deloitte are references to Deloitte LLP, which is among the country's leading professional services firms. Deloitte LLP is the United Kingdom member firm of Deloitte Touche Tohmatsu (‘DTT’), a Swiss Verein, whose member firms are legally separate and independent entities. Please see www.deloitte.co.uk\about for a detailed description of the legal structure of DTT and its member firms.
The information contained in this press release is correct at the time of going to press.